Proactive Investors - Run By Investors For Investors

The Green Organic Dutchman achieves major milestone as it begins cannabis sales to medical patients

The company will start shipping its Unite Organic strain to over 200 medical patients in Canada
cannabis plant farm
TGOD’s cannabis is grown in living soil without synthetic fertilizers, pesticides or herbicides

The Green Organic Dutchman Holdings Ltd (TSE:TGOD) (OTCMKTS:TGODF) announced Monday that it has begun selling cannabis to a national network of medical patients, marking a major milestone in the company’s production strategy.

The launch is a limited rollout of the company’s certified-organic cannabis to a select group of patients across Canada known as The Growers’ Circle, allowing the company to perfect its distribution ahead of a planned production ramp-up later this year.

The Toronto-based company is now shipping its Unite Organic strain to more than 200 medical patients within Canada and plans to expand the list of Growers’ Circle members as more supply comes online.

READ: The Green Organic Dutchman ends 2018 with strong balance sheet, liquidity

“The launch of the Growers’ Circle is another significant moment in TGOD’s commercial story,” said Brian Athaide, the company’s CEO. “Our certified-organic cannabis is a premium experience for patients. We are proud of our product and excited to be sharing it with Growers’ Circle members.”

The company’s cannabis is grown in living soil without synthetic fertilizers, pesticides or herbicides, earning certified organic status by global certification bodies ECOCERT and Pro-cert.

Shares of The Green Organic Dutchman were up nearly 3% to $4.89 in Toronto and 2% to US$3.64 south of the border on Monday afternoon.

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full TGOD profile View Profile

The Green Organic Dutchman Holdings Ltd Timeline

Related Articles

Strainsecure platform
06:00
The company’s blockchain-based platform is designed to guarantee product quality and genetics throughout the cannabis supply chain from genome to patient
data graphic
March 22 2019
The Toronto company is busy meeting what it says is significant demand by building a data asset covering the medical cannabis sector
A cannabis plant shown next to an oil-based product
April 23 2019
THC is executing a medicinal cannabis strategy in Australia, New Zealand and Canada and is looking to Asian markets.
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use